Molecular classification of familial non-BRCA1/BRCA2 breast cancer

Research output: Contribution to journalArticle

Standard

Molecular classification of familial non-BRCA1/BRCA2 breast cancer. / Hedenfalk, Ingrid; Ringnér, Markus; Ben-Dor, Amir; Yakhini, Zohar; Chen, Yidong; Chebil, Gunilla; Ach, R; Loman, Niklas; Olsson, Håkan; Meltzer, Paul; Borg, Åke; Trent, Jeffrey.

In: Proceedings of the National Academy of Sciences, Vol. 100, No. 5, 2003, p. 2532-2537.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

Hedenfalk, Ingrid ; Ringnér, Markus ; Ben-Dor, Amir ; Yakhini, Zohar ; Chen, Yidong ; Chebil, Gunilla ; Ach, R ; Loman, Niklas ; Olsson, Håkan ; Meltzer, Paul ; Borg, Åke ; Trent, Jeffrey. / Molecular classification of familial non-BRCA1/BRCA2 breast cancer. In: Proceedings of the National Academy of Sciences. 2003 ; Vol. 100, No. 5. pp. 2532-2537.

RIS

TY - JOUR

T1 - Molecular classification of familial non-BRCA1/BRCA2 breast cancer

AU - Hedenfalk, Ingrid

AU - Ringnér, Markus

AU - Ben-Dor, Amir

AU - Yakhini, Zohar

AU - Chen, Yidong

AU - Chebil, Gunilla

AU - Ach, R

AU - Loman, Niklas

AU - Olsson, Håkan

AU - Meltzer, Paul

AU - Borg, Åke

AU - Trent, Jeffrey

PY - 2003

Y1 - 2003

N2 - In the decade since their discovery, the two major breast cancer susceptibility genes BRCA1 and BRCA2, have been shown conclusively to be involved in a significant fraction of families segregating breast and ovarian cancer. However, it has become equally clear that a large proportion of families segregating breast cancer alone are not caused by mutations in BRCA1 or BRCA2. Unfortunately, despite intensive effort, the identification of additional breast cancer predisposition genes has so far been unsuccessful, presumably because of genetic heterogeneity, low penetrance, or recessive/polygenic mechanisms. These non-BRCA1/2 breast cancer families (termed BRCAx families) comprise a histopathologically heterogeneous group, further supporting their origin from multiple genetic events. Accordingly, the identification of a method to successfully subdivide BRCAx families into recognizable groups could be of considerable value to further genetic analysis. We have previously shown that global gene expression analysis can identify unique and distinct expression profiles in breast tumors from BRCA1 and BRCA2 mutation carriers. Here we show that gene expression profiling can discover novel classes among BRCAx tumors, and differentiate them from BRCA1 and BRCA2 tumors. Moreover, microarray-based comparative genomic hybridization (CGH) to cDNA arrays revealed specific somatic genetic alterations within the BRCAx subgroups. These findings illustrate that, when gene expression-based classifications are used, BRCAx families can be grouped into homogeneous subsets, thereby potentially increasing the power of conventional genetic analysis.

AB - In the decade since their discovery, the two major breast cancer susceptibility genes BRCA1 and BRCA2, have been shown conclusively to be involved in a significant fraction of families segregating breast and ovarian cancer. However, it has become equally clear that a large proportion of families segregating breast cancer alone are not caused by mutations in BRCA1 or BRCA2. Unfortunately, despite intensive effort, the identification of additional breast cancer predisposition genes has so far been unsuccessful, presumably because of genetic heterogeneity, low penetrance, or recessive/polygenic mechanisms. These non-BRCA1/2 breast cancer families (termed BRCAx families) comprise a histopathologically heterogeneous group, further supporting their origin from multiple genetic events. Accordingly, the identification of a method to successfully subdivide BRCAx families into recognizable groups could be of considerable value to further genetic analysis. We have previously shown that global gene expression analysis can identify unique and distinct expression profiles in breast tumors from BRCA1 and BRCA2 mutation carriers. Here we show that gene expression profiling can discover novel classes among BRCAx tumors, and differentiate them from BRCA1 and BRCA2 tumors. Moreover, microarray-based comparative genomic hybridization (CGH) to cDNA arrays revealed specific somatic genetic alterations within the BRCAx subgroups. These findings illustrate that, when gene expression-based classifications are used, BRCAx families can be grouped into homogeneous subsets, thereby potentially increasing the power of conventional genetic analysis.

U2 - 10.1073/pnas.0533805100

DO - 10.1073/pnas.0533805100

M3 - Article

VL - 100

SP - 2532

EP - 2537

JO - Proceedings of the National Academy of Sciences

T2 - Proceedings of the National Academy of Sciences

JF - Proceedings of the National Academy of Sciences

SN - 1091-6490

IS - 5

ER -